Transferrin receptor (TFR) is overexpressed in many types of cancers, such as liver cancer 75, kidney cance 76, glioma 77, and pancreatic cancer 78, compared to non-tumor tissues, which makes it a promising target for cancer therapy. This evidence concerns the gene TFRC and neoplasm.